3654 results for «397»

Filter By

3654 results

PCR's Got Talent Award, best abstract & best case Awards

23 May 2025 – From EuroPCR 2025

Celebrate the outstanding achievements recognized at PCR's Got Talent Award, highlighting the best abstracts and cases from the conference, showcasing innovation and excellence in interventional cardiology.

PCR's Got Talent Award, best abstract & best case Awards

Welcome to EuroPCR 2025

20 May 2025 – From EuroPCR 2025

Welcome to EuroPCR 2025, the premier event for interventional cardiology innovation and education, where leaders and professionals gather to shape the future of cardiovascular care.

Welcome to EuroPCR 2025

EAPCI Fellowship Grant Awards

21 May 2025 – From EuroPCR 2025

Celebrate the achievements of emerging cardiology leaders with the EAPCI Fellowship Grant Awards session. This presentation highlights the awarded fellows' contributions and the impact of fellowship support on advancing interventional cardiology research and clinical practice.

EAPCI Fellowship Grant Awards

EuroPCR 2025 Closing Ceremony

23 May 2025 – From EuroPCR 2025

Conclude your conference experience with the EuroPCR 2025 Closing Ceremony, celebrating the achievements, innovations, and advancements presented throughout the event, and setting the stage for future developments in interventional cardiology.

EuroPCR 2025 Closing Ceremony

Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award

21 May 2025 – From EuroPCR 2025

Celebrate innovation and research excellence in interventional cardiology with the Jon DeHaan Foundation Award and Michele Pighi Young Investigator Award session. This session highlights groundbreaking work and emerging talent shaping the future of cardiovascular interventions.

Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award

Andreas Grüntzig Ethica Award

22 May 2025 – From EuroPCR 2025

Recognize excellence in interventional cardiology with the prestigious Andreas Grüntzig Ethica Award. This session honors outstanding contributions and ethical standards that advance the field and improve patient care worldwide.

Andreas Grüntzig Ethica Award

EuroIntervention 20th anniversary and annual editorial meeting – All EuroPCR participants welcome

22 May 2025 – From EuroPCR 2025

Mark the 20th anniversary of EuroIntervention with this special annual editorial meeting open to all EuroPCR participants. Reflect on the journal's achievements, discuss future directions, and engage with leaders in interventional cardiology to shape the evolving landscape of cardiovascular research and practice.

EuroIntervention 20th anniversary and annual editorial meeting – All EuroPCR participants welcome

Refractory heart failure: combining oral therapy and device is key

21 May 2025 – From EuroPCR 2025

Address refractory heart failure management through combined oral therapy and device interventions. This session helps identify patients needing treatment escalation, reviews contemporary cardiovascular intervention indications, and emphasizes achieving optimal synergy between pharmacologic and device-based therapies through clinical case discussions.

Refractory heart failure: combining oral therapy and device is key

ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

07 Nov 2022

Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation. 

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

IMPELLA supported PCI via a single access sheath - Introduction and rapid adoption: the Power of Social Media

22 Dec 2020

This manuscript examines Impella single access technique, which provides a case example of the central role social media can play in the introduction of a new interventional approach.

IMPELLA single access technique: Introduction via social media

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

05 Sep 2023

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Alessandro Sticchi

Author

Alessandro Sticchi
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030

29 Aug 2021

Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.

Vijay Kunadian

Author

Vijay Kunadian
ESC Congress 2021 - Global burden of cardiovascular disease in women; 20/20 vision for 2030: report of The Lancet commission

The 2023 ESH Hypertension Guidelines revisit the role of renal denervation

05 Sep 2023

The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...

Lucas Lauder

Author

Lucas Lauder

Author

Felix Mahfoud
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation

Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)

08 Apr 2024

Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.

Ali Nazmi Calik

Author

Ali Nazmi Calik
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques
Didn’t find what you were looking for?